Jens Vollmar studied medicine at the university Erlangen-Nuremberg where he acquired his doctor title at the institute for virology working on herpes viruses. Since 1995 he held positions in clinical research at SmithKline Beecham, GlaxoSmithKline and Amgen with focus on biopharmaceutical products and vaccines.
From 2002 he was medical director of Bavarian Nordic where he set up a clinical development, safety and regulatory affairs department. Amongst others he collaborated closely with US government and US FDA regarding the development of new smallpox and HIV vaccines.
Since 2007 he is head of the medical therapeutic area vaccines, tropical and travel medicine at GSK in Munich Germany. In this position he is in charge of medical affairs and clinical development of the entire GSK vaccine portfolio in Germany.